celecoxib and thromboplastin

celecoxib has been researched along with thromboplastin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bea, F; Bennett, BJ; Blessing, E; Campbell, LA; Kreuzer, J; Kuo, CC; Rosenfeld, ME1
Gay, S; Greutert, H; Hermann, M; Lüscher, TF; Ruschitzka, F; Steffel, J; Tanner, FC1
Akhmedov, A; Fähndrich, C; Lüscher, TF; Ruschitzka, F; Steffel, J; Tanner, FC1
Ai, Y; Dey, SK; Ghosh, M; Hla, T; Luyendyk, JP; Mackman, N; Peters, JM; Romeo, E; Wang, H1
Chen, HN; Huang, YT; Wan, YL; Wang, HY; Yang, YM; Zhuang, Y1
Kaneshiro, T; Kawamori, T; Maalouf, S; Maruyama, T; Okumura, M; Uflacker, A1
Abo-Elmatty, DM; Ahmed, AA; El-Baz, AA; Mosaad, SM; Moustafa, YM; Zaitone, SA1

Other Studies

7 other study(ies) available for celecoxib and thromboplastin

ArticleYear
Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis.
    Cardiovascular research, 2003, Oct-15, Volume: 60, Issue:1

    Topics: Actins; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Arteriosclerosis; Brachiocephalic Trunk; Celecoxib; Chemokine CCL2; Cholesterol; Cyclooxygenase 2; Isoenzymes; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thromboplastin; Treatment Failure

2003
Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
    Circulation, 2005, Apr-05, Volume: 111, Issue:13

    Topics: Aorta; Celecoxib; Cells, Cultured; Cyclooxygenase Inhibitors; Endothelium, Vascular; Humans; JNK Mitogen-Activated Protein Kinases; Lactones; Mitogen-Activated Protein Kinases; Phosphorylation; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Thromboplastin; Tumor Necrosis Factor-alpha

2005
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
    Biochemical and biophysical research communications, 2006, Oct-20, Volume: 349, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Celecoxib; Cell Line; Endothelium, Vascular; Gene Expression Regulation; Heart Diseases; Humans; Lactones; Muscle, Smooth, Vascular; Pyrazoles; Sulfonamides; Sulfones; Thromboplastin; Thrombosis; Transcription, Genetic; Tumor Necrosis Factor-alpha

2006
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation.
    The Journal of experimental medicine, 2007, Sep-03, Volume: 204, Issue:9

    Topics: Animals; Cannabinoid Receptor Modulators; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Endothelial Cells; HCT116 Cells; Humans; Mice; PPAR delta; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thromboplastin; Transcription, Genetic; Transcriptional Activation

2007
The effect of celecoxib on tissue factor expression in pancreatic cancer cells.
    Chinese medical journal, 2007, Oct-20, Volume: 120, Issue:20

    Topics: Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation; Humans; NF-kappa B; Pancreatic Neoplasms; Pyrazoles; Sulfonamides; Thromboplastin; Tumor Necrosis Factor-alpha

2007
Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells.
    Prostaglandins & other lipid mediators, 2009, Volume: 90, Issue:1-2

    Topics: Blood Coagulation; Bridged Bicyclo Compounds; Caproates; Cardiovascular Diseases; Celecoxib; Cell Line; Cytokines; Dinoprostone; Endothelial Cells; Epoprostenol; Fibrinolytic Agents; Gene Expression Regulation; Humans; Peroxisome Proliferator-Activated Receptors; Pyrazoles; Receptors, Prostaglandin E; Response Elements; Signal Transduction; Sulfonamides; Thromboplastin

2009
Evening primrose oil or forskolin ameliorates celecoxib-enhanced upregulation of tissue factor expression in mice subjected to lipopolysaccharide-induced endotoxemia.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:5

    Topics: Animals; Antithrombin III; Blood Coagulation; Celecoxib; Colforsin; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endotoxemia; Fibrinolytic Agents; gamma-Linolenic Acid; Linoleic Acids; Lipopolysaccharides; Lung; Male; Mice; Oenothera biennis; Peptide Hydrolases; Plant Oils; Thromboplastin; Thrombosis; Up-Regulation

2017